{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:28:10Z","timestamp":1793330890418,"version":"4.5.0"},"reference-count":55,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:00:00Z","timestamp":1498089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:00:00Z","timestamp":1498089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Scabies is caused by\n                    <jats:italic>Sarcoptes scabiei<\/jats:italic>\n                    var.\n                    <jats:italic>hominis<\/jats:italic>\n                    . The disease can be sexually transmitted. Patients\u2019 main complaint is nocturnal itch. Disseminated, excoriated, erythematous papules are usually seen on the anterior trunk and limbs. Crusted scabies occurs in immunocompromised hosts and may be associated with reduced or absent pruritus. Recommended treatments are permethrin 5% cream, oral ivermectin and benzyl benzoate 25% lotion. Alternative treatments are malathion 0.5% aqueous lotion, ivermectin 1% lotion and sulphur 6\u201333% cream, ointment or lotion. Crusted scabies therapy requires a topical scabicide and oral ivermectin. Mass treatment of large populations with endemic disease can be performed with a single dose of ivermectin (200 micrograms\/kg of bodyweight). Partner management needs a look\u2010back period of 2 months. Screening for other\n                    <jats:styled-content style=\"fixed-case\">STI<\/jats:styled-content>\n                    is recommended. Patients and close contacts should avoid sexual contact until completion of treatment and should strictly observe personal hygiene rules when living in crowded spaces. Written information should be provided to suspected cases.\n                  <\/jats:p>","DOI":"10.1111\/jdv.14351","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T05:50:45Z","timestamp":1498110645000},"page":"1248-1253","source":"Crossref","is-referenced-by-count":284,"title":["European guideline for the management of scabies"],"prefix":"10.1111","volume":"31","author":[{"given":"C.M.","family":"Salavastru","sequence":"first","affiliation":[{"name":"Department of Dermato\u2010Pediatry Colentina Clinical Hospital \u201cCarol Davila\u201d University of Medicine and Pharmacy Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Chosidow","sequence":"additional","affiliation":[{"name":"Department of Dermatology H\u00f4pital Henri Mondor AP\u2010HP Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Boffa","sequence":"additional","affiliation":[{"name":"Department of Dermatology Sir Paul Boffa Hospital Floriana Malta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Janier","sequence":"additional","affiliation":[{"name":"STD Clinic H\u00f4pital Saint\u2010Louis AP\u2010HP, and Head of Dermatology Department H\u00f4pital Saint\u2010Joseph Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.S.","family":"Tiplica","sequence":"additional","affiliation":[{"name":"Department of Dermatology II Colentina Clinical Hospital \u201cCarol Davila\u201d University of Medicine and Pharmacy Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,6,22]]},"reference":[{"key":"e_1_2_17_2_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1258\/ijsa.2011.011112","article-title":"European guideline for the management of scabies, 2010","volume":"22","author":"Scott GR","year":"2011","journal-title":"Int J STD AIDS"},{"key":"e_1_2_17_3_1","unstructured":"Scabies \u2013 CDC Resources for Health Professionals.2015. Available at:http:\/\/www.cdc.gov\/std\/tg2015\/ectoparasitic.htm. Accessed 20 June 2016."},{"key":"e_1_2_17_4_1","unstructured":"Classic scabies \u2013 CDC Resources for Health Professionals. Available at:http:\/\/www.cdc.gov\/parasites\/scabies\/health_professionals\/meds.html. Accessed 18 July 2016"},{"key":"e_1_2_17_5_1","unstructured":"ScottG.United Kingdom National Guideline on the Management of Scabies (2007). Available at:www.bashh.org\/documents\/27\/27.pdf. Accessed 20 June 2016."},{"key":"e_1_2_17_6_1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0190-9622(84)70151-4","article-title":"Survival and infectivity of Sarcoptes scabiei var. canis and var. hominis","volume":"11","author":"Arlian LG","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_17_7_1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2133.1975.tb03084.x","article-title":"Mites in the environment of cases of Norwegian scabies","volume":"92","author":"Carslaw J","year":"1975","journal-title":"Br J Dermatol"},{"key":"e_1_2_17_8_1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(99)09458-1","article-title":"Scabies and pediculosis","volume":"355","author":"Chosidow O","year":"2000","journal-title":"Lancet"},{"key":"e_1_2_17_9_1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/QCO.0b013e32835eb8a6","article-title":"Immunology of scabies and translational outcomes: identifying the missing links","volume":"26","author":"Walton SF","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"e_1_2_17_10_1","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1086\/511428","article-title":"Scabies and pediculosis pubis: an update of treatment regimens and general review","volume":"44","author":"Leone AP","year":"2007","journal-title":"Clin Infect Dis"},{"key":"e_1_2_17_11_1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000327378","article-title":"Canine scabies in humans: a case report and review of the literature","volume":"223","author":"Ayd\u0131ng\u00f6z IE","year":"2011","journal-title":"Dermatology"},{"key":"e_1_2_17_12_1","first-page":"19","article-title":"The scourge of scabies","volume":"49","author":"Kemp DJ","year":"2002","journal-title":"Biologist"},{"key":"e_1_2_17_13_1","first-page":"1718","article-title":"Clinical practices. Scabies","volume":"354","author":"Chosidow O","year":"2006","journal-title":"N Engl J Med"},{"key":"e_1_2_17_14_1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00007611-199403000-00011","article-title":"Crusted (Norwegian) scabies in patients with AIDS: the range of clinical presentations","volume":"87","author":"Schlesinger L","year":"1994","journal-title":"South Med J"},{"key":"e_1_2_17_15_1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaad.2004.12.039","article-title":"Crusted scabies in a patient being treated with infliximab for juvenile rheumatoid arthritis","volume":"52","author":"Pipitone MA","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_17_16_1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jbspin.2011.02.008","article-title":"Crusted Norwegian scabies, an opportunistic infection, with tocilizumab in rheumatoid arthritis","volume":"78","author":"Baccouche K","year":"2011","journal-title":"Joint Bone Spine"},{"key":"e_1_2_17_17_1","first-page":"195","article-title":"Scabies in a patient with rheumatoid arthritis treated with adalimumab \u2013 a case report","volume":"23","author":"Markovic I","year":"2015","journal-title":"Acta Dermatovenerol Croat"},{"key":"e_1_2_17_18_1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jinf.2004.08.033","article-title":"Crusted scabies: clinical and immunological findings in seventy\u2010eight patients and a review of the literature","volume":"50","author":"Roberts LJ","year":"2005","journal-title":"J Infect"},{"key":"e_1_2_17_19_1","first-page":"2569","volume-title":"Fitzpatrick's Dermatology in General Medicine","author":"Burkhart CN","year":"2012"},{"key":"e_1_2_17_20_1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archderm.1973.01620160042011","article-title":"Scraping for human scabies. A better method for positive preparations","volume":"107","author":"Muller G","year":"1973","journal-title":"Arch Dermatol"},{"key":"e_1_2_17_21_1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1001\/archderm.1973.01620240070025","article-title":"Scabies scraping","volume":"108","author":"Hoke AW","year":"1973","journal-title":"Arch Dermatol"},{"key":"e_1_2_17_22_1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaad.2006.07.025","article-title":"Accuracy of standard dermoscopy for diagnosing scabies","volume":"56","author":"Dupuy A","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_17_23_1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archderm.1997.03890420091011","article-title":"Epiluminescence microscopy. A new approach to in vivo detection of Sarcoptes scabiei","volume":"133","author":"Argenziano G","year":"1997","journal-title":"Arch Dermatol"},{"key":"e_1_2_17_24_1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1258\/0956462021924848","article-title":"Are sexually transmitted infections associated with scabies?","volume":"13","author":"David N","year":"2002","journal-title":"Int J STD AIDS"},{"key":"e_1_2_17_25_1","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass drug administration for scabies control in a population with endemic disease","volume":"373","author":"Romani L","year":"2015","journal-title":"N Engl J Med"},{"key":"e_1_2_17_26_1","doi-asserted-by":"crossref","first-page":"e0004151","DOI":"10.1371\/journal.pntd.0004151","article-title":"Impact of an ivermectin mass drug administration on scabies prevalence in a remote Australian aboriginal community","volume":"9","author":"Kearns TM","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"e_1_2_17_27_1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/ijd.12353","article-title":"Scabies community prevalence and mass drug administration in two Fijian villages","volume":"53","author":"Haar K","year":"2014","journal-title":"Int J Dermatol"},{"key":"e_1_2_17_28_1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2310\/7750.2013.12123","article-title":"Comparative trial of oral ivermectin versus sulfur 8% ointment for the treatment of scabies","volume":"17","author":"Goldust M","year":"2013","journal-title":"J Cutan Med Surg"},{"key":"e_1_2_17_29_1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4103\/0378-6323.100571","article-title":"Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies","volume":"78","author":"Chhaiya SB","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_17_30_1","first-page":"251","article-title":"Treatment of scabies: comparison of ivermectin vs. lindane lotion 1%","volume":"20","author":"Mohebbipour A","year":"2012","journal-title":"Acta Dermatovenerol Croat"},{"key":"e_1_2_17_31_1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4103\/0378-6323.84063","article-title":"Topical permethrin and oral ivermectin in the management of scabies: A prospective, randomized, double blind, controlled study","volume":"77","author":"Sharma R","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_17_32_1","first-page":"11","article-title":"The efficacy of topical and oral ivermectin in the treatment of human scabies","volume":"61","author":"Panahi Y","year":"2015","journal-title":"Ann Parasitol"},{"key":"e_1_2_17_33_1","first-page":"284","article-title":"Comparing the efficacy of oral ivermectin vs malathion 0.5% lotion for the treatment of scabies","volume":"12","author":"Goldust M","year":"2014","journal-title":"Skinmed"},{"key":"e_1_2_17_34_1","doi-asserted-by":"crossref","first-page":"e0004246","DOI":"10.1371\/journal.pntd.0004246","article-title":"Long term control of scabies fifteen years after an intensive treatment programme","volume":"9","author":"Marks M","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"e_1_2_17_35_1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archderm.1990.01670260037006","article-title":"Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies","volume":"126","author":"Schultz MW","year":"1990","journal-title":"Arch Dermatol"},{"key":"e_1_2_17_36_1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archderm.135.6.651","article-title":"Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies","volume":"135","author":"Chouela EN","year":"1999","journal-title":"Arch Dermatol"},{"key":"e_1_2_17_37_1","unstructured":"WHO Model Prescribing Information: Drugs Used in Skin Diseases (1997). [cited May 31 2016]. Available from:http:\/\/apps.who.int\/medicinedocs\/en\/d\/Jh2918e\/27.1.html."},{"key":"e_1_2_17_38_1","first-page":"1015","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2015"},{"key":"e_1_2_17_39_1","first-page":"531","article-title":"A comparative study between 10 per cent sulfur ointment and 0.3 per cent gamma benzene hexachloride gel in the treatment of scabies in children","volume":"86","author":"Singalavanija S","year":"2003","journal-title":"J Med Assoc Thai"},{"key":"e_1_2_17_40_1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1525-1470.1991.tb00844.x","article-title":"Therapeutic efficacy, secondary effects, and patient acceptability of 10% sulfur in either pork fat or cold cream for the treatment of scabies","volume":"8","author":"Avila\u2010Romay A","year":"1991","journal-title":"Pediatr Dermatol"},{"key":"e_1_2_17_41_1","first-page":"69","article-title":"Efficacy and tolerability of natural synergised pyrethrins in a new thermo labile foam formulation in topical treatment of scabies: a prospective, randomised, investigator\u2010blinded, comparative trial vs. permethrin cream","volume":"13","author":"Amerio P","year":"2003","journal-title":"Eur J Dermatol"},{"key":"e_1_2_17_42_1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1471-0528.2007.01290.x","article-title":"Safety of benzyl benzoate lotion and permethrin in pregnancy: a retrospective matched cohort study","volume":"114","author":"Mytton OT","year":"2007","journal-title":"Br J Obstet Gynecol"},{"key":"e_1_2_17_43_1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/0890334403258133","article-title":"Antiparasitic drugs and lactation: focus on anthelmintics, scabicides, and pediculosis","volume":"19","author":"Porto I","year":"2003","journal-title":"J Hum Lact"},{"key":"e_1_2_17_44_1","first-page":"1145","volume-title":"Drugs in pregnancy and lactation","author":"Briggs GG","year":"2011"},{"key":"e_1_2_17_45_1","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski KA","year":"2015","journal-title":"Centers Disease Control Prevent MMWR Recomm Rep"},{"key":"e_1_2_17_46_1","unstructured":"Malathion. Available at:http:\/\/lecrat.fr\/articleSearchSaisie.php?recherche=malathion. Accessed 12 April 2017."},{"key":"e_1_2_17_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000320.pub2"},{"key":"e_1_2_17_48_1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0190-9622(00)90131-2","article-title":"A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies","volume":"42","author":"Usha V","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_17_49_1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMct0910329","article-title":"Permethrin and ivermectin for scabies","volume":"362","author":"Currie BJ","year":"2010","journal-title":"N Engl J Med"},{"key":"e_1_2_17_50_1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0035-9203(00)90454-1","article-title":"Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis","volume":"94","author":"Walton SP","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"e_1_2_17_51_1","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1086\/421776","article-title":"First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei","volume":"39","author":"Currie BJ","year":"2004","journal-title":"Clin Infect Dis"},{"key":"e_1_2_17_52_1","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1371\/journal.pntd.0000354","article-title":"The effect of insecticide synergists on the response of scabies mites to pyrethroid acaricides","volume":"3","author":"Pasay C","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"e_1_2_17_53_1","doi-asserted-by":"crossref","first-page":"O139","DOI":"10.1111\/1469-0691.12334","article-title":"Molecular survey of knockdown resistance to pyrethroids in human scabies mites","volume":"20","author":"Andriantsoanirina V","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"e_1_2_17_54_1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/jdv.13181","article-title":"2015 European guidelines for the management of partners of persons with sexually transmitted infections","volume":"29","author":"Tiplica GS","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_2_17_55_1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0956462412472804","article-title":"2012 BASHH statement on partner notification for sexually transmissible infections","volume":"24","author":"McClean H","year":"2013","journal-title":"Int J STD AIDS"},{"key":"e_1_2_17_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009943.pub2"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.14351","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.14351","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.14351","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.14351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:39:40Z","timestamp":1791279580000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.14351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,22]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1111\/jdv.14351"],"URL":"https:\/\/doi.org\/10.1111\/jdv.14351","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,22]]}}}